Search Results

Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives.

• Authors : Zhao J; Department of Pharmacy, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.

Subjects: Pharmacogenetics* ; Polymorphism, Genetic*; Humans

• Source: Paediatric drugs [Paediatr Drugs] 2023 May; Vol. 25 (3), pp. 301-319. Date of Electronic Publication: 2023 Jan 27.Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients.

• Authors : Lemke A; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.; Wright J

Subjects: Pharmacogenetics* ; Organ Transplantation*/Organ Transplantation*/Organ Transplantation*/adverse effects; Humans

• Source: Pharmacotherapy [Pharmacotherapy] 2023 Jul; Vol. 43 (7), pp. 596-608. Date of Electronic Publication: 2023 Apr 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics.

• Authors : Brunet, Mercè; Pastor-Anglada, Marçal

Subjects: PHARMACOGENOMICS; PHARMACODYNAMICS; TACROLIMUS

• Source: Pharmaceutics; Sep2022, Vol. 14 Issue 9, pN.PAG-N.PAG, 17p

Record details

The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center.

• Authors : Abdel-Kahaar, Emaad; Winter, Stefan; Tremmel, Roman

Subjects: KIDNEY transplantation; TACROLIMUS; HLA histocompatibility antigens

• Source: Frontiers in Genetics; 9/26/2019, p1-12, 12p

Record details

Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.

• Authors : Guy-Viterbo, Vanessa; Baudet, Henry; Elens, Laure

• Source: Pharmacogenomics; Jul2014, Vol. 15 Issue 9, p1207-1221, 15p

Record details

Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.

• Authors : Ferraresso, Mariano; Tirelli, Amedea; Ghio, Luciana

Subjects: CYTOCHROMES; HEMOPROTEINS; BIOLOGICAL pigments

• Source: Pediatric Transplantation; May2007, Vol. 11 Issue 3, p296-300, 5p, 1 Chart, 1 Graph

Record details

Influence of CYP3A4*22 and CYP3A5*3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patients.

• Authors : Ebid, Abdel‐Hameed Ibrahim Mohamed; Ismail, Dina Ahmed; Lotfy, Neama M.

Subjects: RESEARCH; PHARMACOGENOMICS; DRUG overdoseEGYPT

• Source: Journal of Clinical Pharmacy & Therapeutics. Dec2022, Vol. 47 Issue 12, p2255-2263. 9p.

Record details

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.

• Authors : Zhu, Jing; Patel, Tejendra; Miller, Jordan A.

Subjects: HEMATOPOIETIC stem cells; STEM cell transplantation; DRUG monitoring

• Source: International Journal of Molecular Sciences; 2/1/2020, Vol. 21 Issue 3, p858, 1p, 1 Diagram, 4 Charts, 3 Graphs

Record details

Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients.

• Authors : Kurzawski, Mateusz¹; Malinowski, Damian¹; Dziewanowski, Krzysztof¹

• Source: Pharmacogenetics. Aug2014, Vol. 24 Issue 8, p397-400. 4p.

Record details

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.

• Authors : Moes, D.; Bent, S.; Swen, J.

Subjects: BIOTRANSFORMATION (Metabolism); DOSE-response relationship in biochemistry; GENETIC polymorphisms

• Source: European Journal of Clinical Pharmacology; Feb2016, Vol. 72 Issue 2, p163-174, 12p, 1 Diagram, 4 Charts, 5 Graphs

Record details